Page results
-
This page aims to provide information about the syndrome haemophagocytic lymphohistiocytosis (HLH).
-
How we use your information at UCLH: what you need to know.
-
The pancreatobiliary department at UCLH is one of few centres in the UK to provide a patient-centred, comprehensive advanced interventional endoscopy service for diseases of the pancreas and biliary tree.
-
Irreversible Electroporation for Prostate Cancer (IRE or Nanoknife™) patient information page.
-
Our thoracic/respiratory medicine service offers a comprehensive inpatient and outpatient medical service for adults with conditions affecting the lungs.
-
This patient information contains contraceptive advice for patients who have received Sugammadex.
-
Contractual screening for NGOs, Governmental organisations, academic institutions and private companies. Pre-assignment health reviews for medical fitness to travel
-
Information on the different ways you can travel to University College London Hospitals (UCLH) if you don’t qualify for patient transport. It also includes advice on financial support that may be available to you.
-
This page has been written for patients who have been recommended hormone therapy for prostate cancer. It explains what the treatment involves, describes side-effects you may experience, and how best to cope with them.
-
Parenteral Nutrition, also know as PN, is used to feed extremely premature or unwell babies.
File results
-
FOI/2024/0401 - Hospital treatments for abortion complications
-
FOI/2024/0402 - Various IT systems used at the Trust
-
FOI/2024/0403 - Risk Policy and corporate risk register
-
FOI/2024/0406 - Staff and patient discrimination complaints in 2021, 2022 and 2023
-
FOI/2024/0409 - Number of A&E attendees with mental health complaints from 2022 to 2024
-
FOI/2024/0412 - Healthcare travel costs scheme for patients
-
FOI/2024/0415 - Biologic and targeted medications within dermatology medicine
-
FOI/2024/0416 - Home dialysis treatment
-
FOI/2024/0417 - Funding for point-of-care home blood monitoring devices for cancer patients
-
FOI/2024/0420 - Commercialisation of NHS patient data